Status:
UNKNOWN
Diagnosis and Treatment of Patients With Femoroacetabular Impingement Syndrome
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
La Trobe University
Duke University
Conditions:
Femoroacetabular Impingement
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This prospective study with a two-group comparison design investigates the effectiveness of 12-weeks of semi-structured and supervised physiotherapist-led treatment on self-reported hip and groin func...
Detailed Description
The treatment of femoroacetabular impingement syndrome (FAIS) consists of wait-and-see, physiotherapist-led treatment, and/or hip surgery. The primary indication for hip surgery is based on imaging fi...
Eligibility Criteria
Inclusion
- Activity-related longstanding hip and/or groin pain for \>3 months
- Known anterior and/or medial groin pain during the FADIR test with a pain severity of ≥2/10 on NRS.
- Radiological findings on plain radiographs of cam morphology defined as alpha angle \>55° on a lateral view.
Exclusion
- Inguinal-related groin pain diagnosed according to Doha Agreement.
- Pubic-related groin pain diagnosed according to Doha Agreement.
- Evidence of pre-existing hip osteoarthritis, defined as a joint space width \<3 mm at the lateral sourcil on anterior-posterior pelvic radiograph.
- Previous hip pathology such as Perthes' disease, slipped upper femoral epiphysis, hip dysplasia defined as a Lateral Center Edge Angle \<25°, or avascular necrosis.
- Other causes of hip and groin pain identified by the orthopedic surgeon during the clinical examination, such as stress fracture of the femoral neck, referred pain from the facet joint, referred pain from the sacroiliac joint, or other competing diagnosis (rheumatoid arthritis, cancer etc.)
- Previous hip injury such as acetabular fracture, hip dislocation, or femoral neck fracture.
- Previous intra- or extra-articular hip surgery.
- Pregnant.
- Intra-articular steroid hip injection during the preceding 3 months.
Key Trial Info
Start Date :
March 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 12 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03846817
Start Date
March 12 2019
End Date
March 12 2021
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All part of the study is conducted at Department of Orthopedic Department, Hvidovre Hospital
Copenhagen, Denmark